Decision DX-melanoma testing

Ended Awarded Last action

Contract number
36C26119N0676
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Mather, CA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$38,250
Original award $38,250

About this award

Castle Biosciences, Inc. was awarded a $0.00 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The contract calls for Castle Biosciences to provide its DECISION DX-MELANOMA TESTING to the agency. This diagnostic test assists in determining the risk of metastasis for patients diagnosed with melanoma. Performance will occur in Mather, California, with no set-aside designation applied. As the steward of veterans' healthcare, this award supports the VA's mission to provide state-of-the-art medical technologies that improve health outcomes for those it serves.

Quick answers

Who was awarded contract 36C26119N0676?

36C26119N0676 was awarded to Castle Biosciences, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on July 9, 2019.

How much is contract 36C26119N0676 worth?

The government has obligated $0 on 36C26119N0676.

Is contract 36C26119N0676 an order under another contract?

Yes. 36C26119N0676 is a delivery order under 36C26119D0081, an indefinite delivery contract.

Was contract 36C26119N0676 competed?

The extent of competition for 36C26119N0676 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award